Nancy Lurker Insider Trading
Get free email notifications about insider trading for Nancy Lurker.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nancy Lurker. Nancy Lurker is a CEO in Interpace Diagnostics Group, Inc. ($PDII) and a President & CEO in pSivida Corp. ($PSDV) and a President and CEO in pSivida Corp. ($PSDV) and a in Aquestive Therapeutics, Inc. ($AQST) and a Director in Mallinckrodt plc ($MNK).
Address: C/O PDI INC., SADDLE RIVER EXEC. CENTRE 1 RT 17 SOUTH SADDLE RIVER 07458 NJ
Companies in which Nancy Lurker is an Insider
Aquestive Therapeutics, Inc.
Trading Symbol: AQSTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nancy Lurker:
Holdings: 0 shares
Latest Transaction: Jun 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EyePoint Pharmaceuticals, Inc.
Trading Symbol: EYPTIndustry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Nancy Lurker: President & CEO, President and CEO
Holdings: 96,579 shares
Current Value: $160,321
Latest Transaction: Feb 23 2021
$EYPT Market Capitalization: $60.15M
$EYPT Previous Close: $1.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INTERPACE BIOSCIENCES, INC.
Trading Symbol: IDXGIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Nancy Lurker: CEO
Holdings: 871,681 shares
Latest Transaction: Mar 09 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Mallinckrodt plc
Trading Symbol: MNKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nancy Lurker: Director
Holdings: 10,507 shares
Current Value: $532,495
Latest Transaction: Mar 18 2016
$MNK Market Capitalization: $5.32B
$MNK Previous Close: $50.68
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Nancy Lurker
Sentiment: All, AQST, EYPT, IDXG, MNK
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 23 2021 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 13,717 | 0 | 13,718 | |
Feb 23 2021 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 13,717 | 0 | 96,579 | 82.9 K to 96.6 K (+16.55 %) |
Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 124,667 | 0 | 249,333 | |
Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 124,667 | 0 | 784,467 | 659.8 K to 784.5 K (+18.89 %) |
Jun 30 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 40,000 | 0 | 0 | |
Jun 30 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 40,000 | 0 | 659,800 | 619.8 K to 659.8 K (+6.45 %) |
Jun 18 2020 | AQST | Aquestive Therapeu ... | Lurker Nancy | Option Exercise | A | 5.30 | 14,000 | 74,200 | 14,000 |